Clinical Updates in Drug-Eluting Technologies for the Treatment of Peripheral Vascular Disease

 

NY Endovascular Summit
Avatar

DCB in Real-World Lesions: What Is the Data?

By NY Endovascular Summit FEATURING Fabrizio Fanelli
By NY Endovascular Summit FEATURING Fabrizio Fanelli
798 views
December 2, 2021
0 Comments
Login to view comments. Click here to Login
Clinical Updates in Drug-Eluting Technologies for the Treatment of Peripheral Vascular Disease
17:00
William Gray

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized St…

04:50
NY Endovascular Summit

COMPARE-Pilot RCT: 2-Year Results of RANGER DCB vs. IN.PACT DCB

Feat. D. Scheinert
12:23
KC Vascular Symposium 2022

Drug Eluting Balloons and Stents for PAD: Are They Safe?

Feat. B. Custer
10:58
NY Endovascular Summit

DCB in Real-World Lesions: What Is the Data?

Feat. F. Fanelli
12:45
NY Endovascular Summit

My Algorithm for Definitive Therapy in Severely Calcific SFA CTO: DE…

Feat. B. DeRubertis
17:27
ARCH Advanced Revascularization Symposium

Paclitaxel or Limus: What Is the Future in Drug Eluting Therapies?

Feat. C. Walker
19:38
NY Endovascular Summit

Drug Coated Balloons and Mortality in Peripheral Vascular Interventi…

Feat. E. Secemsky
09:47
NY Endovascular Summit

Therapy of Choice for In-Stent Restenosis

Feat. E. Genovese
10:46
NY Endovascular Summit

DCB vs. DES in Real World Lesions: How Do I Choose?

Feat. K. Rosenfield